It's My Life
It's My Life It's My Life Hemophilia Village
Information for Health Care Professionals
Product Information Indication/Safety Information Tell a Friend Site Map
It's My Life

Home
About Hemophilia
Programs & Services
Treating Hemophilia
About BeneFIX
About ReFacto
Personal Stories
News & Resources
News
News Archive
Events Calendar
Online Resources
Publications
Wyeth & Hemophilia
Wyeth
News Archive

 

SHARING A BRIGHTER TOMORROW: WYETH/GENETICS INSTITUTE ANNOUNCES SOOZIE COURTER SCHOLARSHIP WINNERS
Seventeen Students with Hemophilia Earn Awards

The Wyeth/Genetics Institute (GI) Hemophilia Group announced in June 2001 the winners of its fifth annual Soozie Courter Sharing a Brighter Tomorrow Hemophilia Scholarship Program. For the 2001-2002 school year, Wyeth/Genetics Institute awarded twelve $5,000 college scholarships, two $5,000 graduate scholarships, and three $1,000 vocational scholarships.

The winners of the college scholarships include: Travis Bashore, University of Cincinnati, Cincinnati, Ohio; Benjamin Martell, Williams College, Williamstown, Mass.; Hunter Norman, North Carolina State University, Raleigh, N.C.; Cleaven R. Pagani, University of Victoria, Victoria, B.C. (Canada); Richard Tyler Strodtman, University of Missouri, Columbia, Mo.; James B. VanBruggen, Iowa State University, Aimes, Iowa; Kenneth J. Violetto, St. John's University, Jamaica, N.Y.; Beau Jeffrey Ward, Trinity University, San Antonio, Texas; Travis Ward, University of Texas at Austin, Austin, Texas; Jeffrey Mark Jantz, Oklahoma State University, Stillwater, Okla.; Matthew M. Stinger, Seton Hall University, South Orange, N.J.. The winners of the graduate scholarships are Patrick J. Kenney, Vermont Law School, South Royalton, Vt., and Danielle Stueber, Finch University of Health Sciences, The Chicago Medical School, Chicago, Ill The three vocational scholarship winners are: Terrance Armstrong, Heacock Jewelers, Salem, Ore.; Chad O'Neill, British Columbia Institute of Technology, British Columbia (Canada); and Lyf E. Stolte, Rosebud School of the Arts, Rosebud, Alberta (Canada). All winners have either hemophilia A or B.

"We are deeply committed to the hemophilia community, and the annual scholarship program is a way to formally recognize the academic and personal achievements of these students," said Neal Fitzpatrick, director, North American Hemophilia Products, Wyeth/GI. "It's also a way for Wyeth/GI to show our support for young adults living with hemophilia."

To be eligible for the scholarships, students must be either a high school senior or have a graduate equivalency diploma (GED) or currently be enrolled in an accredited junior college, college (undergraduate or graduate), or vocational school. Students were judged on the basis of a personal essay or statement, their academic achievements, and recommendations from personal references. Scholarship winners were selected by a committee of hemophilia health care providers after reviewing more than 60 applications.

The scholarships are dedicated to the memory of Soozie Courter and her contributions to the hemophilia community. During her career in the pharmaceutical industry, Courter worked on developing products to treat hemophilia. By naming the scholarships in her honor, Wyeth/GI recognizes Courter's compassion and interest in all issues related to the scientific advancement of hemophilia research.

Hemophilia is a rare, inherited blood clotting disorder for which there currently is no cure. People with hemophilia are deficient in the key proteins that are vital in the clotting cascade to prevent bleeding -- factor VIII (hemophilia A) or factor IX (hemophilia B). Both forms of hemophilia are characterized by spontaneous hemorrhages or prolonged bleeding, typically into joints and soft tissue. In the United States, nearly 4,000 people have hemophilia B and between 15,000 and 17,000 people have hemophilia A.

Through the annual scholarship program, as well as patient assistance and summer camp programs, Wyeth/GI seeks to provide education and assistance to people living with hemophilia. Wyeth/GI is an established leader in the research and development of hemophilia products, and has a strong presence in the hemophilia community. In March of 1999, the National Hemophilia Foundation (NHF) accepted a $2.5 million matching gift by Wyeth/GI to fund research to find cures for bleeding disorders. Wyeth-Ayerst Laboratories is the pharmaceutical division of American Home Products Corporation (NYSE: AHP).

For more information about the scholarship program or Wyeth/GI, please contact your local Wyeth/GI representative, or call (888) 322-6010.

September 6, 2001

Back to News Archives



   
Privacy Policy | Terms and Conditions
The information on this site is only intended for residents of the United States.
© 2007, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101
119533-01